226 related articles for article (PubMed ID: 38102584)
21. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
[TBL] [Abstract][Full Text] [Related]
22. Chinese herbal medicine alleviates the pathogenesis of polycystic ovary syndrome by improving oxidative stress and glucose metabolism via mitochondrial Sirtuin 3 signaling.
Zhang Q; Ren J; Wang F; Li M; Pan M; Zhang H; Qu F
Phytomedicine; 2023 Jan; 109():154556. PubMed ID: 36610149
[TBL] [Abstract][Full Text] [Related]
23. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
[TBL] [Abstract][Full Text] [Related]
24. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
25. Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome.
Cai YL; Zhang F; Dou XX; Zeng HW; Wu GS; Liang YL; Xu XK; Zhao J; Ye J; Zhang WD
J Ethnopharmacol; 2022 Sep; 295():115442. PubMed ID: 35688255
[TBL] [Abstract][Full Text] [Related]
26. microRNA-103 Contributes to Progression of Polycystic Ovary Syndrome Through Modulating the IRS1/PI3K/AKT Signal Axis.
Mu J; Yu P; Li Q
Arch Med Res; 2021 Jul; 52(5):494-504. PubMed ID: 33583602
[TBL] [Abstract][Full Text] [Related]
27. [Study on mechanism of Bushen Culuan Formula in treatment of polycystic ovary syndrome based on network pharmacology and molecular docking].
Ma K; Gong LJ; Chen YX; Tian CD
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2650-2659. PubMed ID: 34296561
[TBL] [Abstract][Full Text] [Related]
28. Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue.
Rabah HM; Mohamed DA; Mariah RA; Abd El-Khalik SR; Khattab HA; AbuoHashish NA; Abdelsattar AM; Raslan MA; Farghal EE; Eltokhy AK
Redox Rep; 2023 Dec; 28(1):2160569. PubMed ID: 36661246
[TBL] [Abstract][Full Text] [Related]
29. Chinese herbal medicine alleviates autophagy and apoptosis in ovarian granulosa cells induced by testosterone through PI3K/AKT1/FOXO1 pathway.
Hu W; Xie N; Pan M; Zhang Q; Zhang H; Wang F; Qu F
J Ethnopharmacol; 2024 Jan; 318(Pt B):117025. PubMed ID: 37567425
[TBL] [Abstract][Full Text] [Related]
30. Exploring the relationship between osteoporosis and polycystic ovary syndrome based on bioinformatics.
Dang CX; Wang D; Yu X; Liu PF; Liu JX
Medicine (Baltimore); 2022 Jun; 101(25):e29434. PubMed ID: 35758378
[TBL] [Abstract][Full Text] [Related]
31. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
[TBL] [Abstract][Full Text] [Related]
32. Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.
Cao S; Hou G; Meng Y; Chen Y; Xie L; Shi B
Dis Markers; 2022; 2022():2141882. PubMed ID: 36157206
[TBL] [Abstract][Full Text] [Related]
33. Network pharmacology and molecular docking study on the treatment of polycystic ovary syndrome with angelica sinensis- radix rehmanniae drug pair.
Li X; Ullah I; Hou C; Liu Y; Xiao K
Medicine (Baltimore); 2023 Nov; 102(46):e36118. PubMed ID: 37986355
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of Heqi san on rat model of polycystic ovary syndrome through the PI3K/AKT pathway.
Zhao H; Zhou D; Chen Y; Liu D; Chu S; Zhang S
Daru; 2017 Oct; 25(1):21. PubMed ID: 29020999
[TBL] [Abstract][Full Text] [Related]
35. Qi Gong Wan ameliorates adipocyte hypertrophy and inflammation in adipose tissue in a PCOS mouse model through the Nrf2/HO-1/Cyp1b1 pathway: Integrating network pharmacology and experimental validation in vivo.
Zheng R; Shen H; Li J; Zhao J; Lu L; Hu M; Lin Z; Ma H; Tan H; Hu M; Li J
J Ethnopharmacol; 2023 Jan; 301():115824. PubMed ID: 36273747
[TBL] [Abstract][Full Text] [Related]
36. Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis.
Wu Y; Liu X; Li G
Sci Rep; 2022 Jan; 12(1):159. PubMed ID: 34997010
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology.
Lin Y; Xiang L; Li X; Tang Q; Meng F; Chen W
Curr Med Chem; 2023; 30(21):2463-2474. PubMed ID: 35532255
[TBL] [Abstract][Full Text] [Related]
38. Construction of a competing endogenous RNA network to identify drug targets against polycystic ovary syndrome.
Wu T; Gao YY; Tang XN; Li Y; Dai J; Zhou S; Wu M; Zhang JJ; Wang SX
Hum Reprod; 2022 Nov; 37(12):2856-2866. PubMed ID: 36223608
[TBL] [Abstract][Full Text] [Related]
39. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
40. Molecular targets of metformin against ovarian cancer based on network pharmacology.
Guo JY; Wang YJ; Li SQ; Wu YP
Chem Biol Drug Des; 2023 Jul; 102(1):88-100. PubMed ID: 36977503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
